If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDunedin Smaller Cos. Investment Trust PLC Regulatory News (DNDL)

  • There is currently no data for DNDL

Corporate Action

21 Jun 2018 07:00

RNS Number : 0617S
Dunedin Smaller Cos Inv Tst PLC
21 June 2018
 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED IN IT ARE NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA.

The information communicated in this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this information is considered to be in the public domain.

LEI: 213800CI43OQT8KBKE03

21 june 2018

DUNEDIN SMALLER companies INVESTMENT trust plc

Result of Strategic Review

The Board of Dunedin Smaller Companies Investment Trust plc (the "Company") has undertaken a strategic review of the Company and its position in the UK smaller companies sector. The Board is aware that the Company's size and the secondary market liquidity in its shares make it challenging to attract new investors in the Company. The Board also believes that these factors have contributed to the discount at which the Company's shares trade. In addition, the recent merger of the Company's manager Aberdeen Asset Management PLC with Standard Life plc has resulted in the Company being managed alongside a company with a very similar UK smaller companies mandate. As a consequence of these factors, the Board decided to undertake the strategic review.

Having considered a number of options and following consultation with the Company's largest shareholders, the Board believes that shareholders, as a whole, still wish to retain exposure to UK smaller companies via an investment trust with a similar mandate managed by the Company's manager, Aberdeen Standard Investments1. Consequently, the Company has agreed, in principle, the terms of a merger with Standard Life UK Smaller Companies Trust plc ("SLS").

The Board believes that the merger of the Company and SLS would provide the Company's shareholders with an investment in a significantly larger investment trust, with a strong investment track record, a stronger rating, a robust discount control mechanism and substantially greater secondary market liquidity, all of which should appeal to a broader range of investors. In particular, the Board believes that a merger would result in a significant increase in the valuation of the Company's shareholders' investment (over the 12 months ended 19 June 2018, the shares of the Company and of SLS traded at average discounts of -17.4% and -3.8% respectively2).

The merger would be effected by way of a scheme of reconstruction of the Company under section 110 of the Insolvency Act 1986 resulting in the voluntary liquidation of the Company and shareholders rolling over their investment in the Company into SLS on the basis of an all-share, nil premium (to NAV) merger, save that the aggregate costs of the Company and SLS would be borne by the Company's shareholders. In accordance with customary practice for such transactions involving investment trusts, the City Code on Takeovers and Mergers will not apply to the transaction. The merger of the Company and SLS would be subject to, inter alia, approval by the shareholders of each of the Company and SLS

The Directors expect to declare, pre-merger, a final interim dividend. Although the merger of the Company and SLS is expected to result in a reduction in the aggregate annual dividends received by the Company's shareholders in the medium term, the final interim dividend is expected to be at least equivalent to the aggregate reduction for the 12 months following the merger3.

James Barnes, the Company's chairman, said: "Dunedin Smaller Companies Trust's size and the secondary market liquidity in its shares makes it challenging to attract new investors. The proposed merger with Standard Life UK Smaller Companies Trust will resolve these issues, creating a merged trust with assets of over £550m and substantially greater secondary market liquidity. As Standard Life UK Smaller Companies Trust has consistently had a substantially stronger rating than the Company, the Board believes that the merger will result in the Company's shareholders benefiting from a significant increase in the market value of their investment."

A circular convening a general meeting to approve the transaction is expected to be sent to the Company's shareholders in due course, together with a prospectus issued by SLS containing details of the SLS shares that the Company's shareholders will receive in exchange for their shares in the Company pursuant to the proposed merger.

Notes: 1Aberdeen Standard Investments is a brand of the investment businesses of Aberdeen Asset Management and Standard Life Investments. 2Discounts are based on the respective net asset values (cum-income, with debt at fair value) and share prices of the Company and SLS over the 12 months ended 19 June 2018. 3Based on the dividends declared by the Company and SLS respectively during the 12 months prior to and ending on 19 June 2018.

Enquiries

Dunedin Smaller Companies Investment Trust plc

James Barnes

T: +44 (0) 131 528 4287

Cantor Fitzgerald Europe

Sue Inglis

T: +44 (0) 20 7894 8016

Aberdeen Standard Investments

Maria Allen

T: +44 (0) 20 7463 6000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
JVEBIGDLBBDBGIG
Date   Source Headline
3rd Aug 201812:55 pmRNSNet Asset Value(s)
2nd Aug 20182:34 pmRNSQuarterly Disclosures
2nd Aug 201812:19 pmRNSNet Asset Value(s)
31st Jul 201812:03 pmRNSNet Asset Value(s)
30th Jul 20181:40 pmRNSNet Asset Value(s)
27th Jul 201812:27 pmRNSNet Asset Value(s)
26th Jul 201812:43 pmRNSNet Asset Value(s)
25th Jul 201812:36 pmRNSNet Asset Value(s)
24th Jul 201812:29 pmRNSNet Asset Value(s)
23rd Jul 20181:12 pmRNSNet Asset Value(s)
20th Jul 201812:36 pmRNSNet Asset Value(s)
19th Jul 201812:02 pmRNSNet Asset Value(s)
18th Jul 201811:28 amRNSNet Asset Value(s)
17th Jul 20181:01 pmRNSNet Asset Value(s)
16th Jul 20181:39 pmRNSNet Asset Value(s)
13th Jul 201812:41 pmRNSNet Asset Value(s)
12th Jul 20183:06 pmRNSPortfolio Disclosures
12th Jul 201812:07 pmRNSNet Asset Value(s)
11th Jul 201812:25 pmRNSNet Asset Value(s)
11th Jul 201810:52 amRNSDoc re. Half Yearly Report
10th Jul 201812:08 pmRNSNet Asset Value(s)
9th Jul 20183:39 pmRNSHolding(s) in Company
9th Jul 201812:48 pmRNSNet Asset Value(s)
6th Jul 201812:18 pmRNSNet Asset Value(s)
5th Jul 20183:34 pmRNSMonth End Net Asset Value(s)
5th Jul 201812:49 pmRNSNet Asset Value(s)
4th Jul 20181:00 pmRNSNet Asset Value(s)
3rd Jul 20181:38 pmRNSNet Asset Value(s)
29th Jun 20181:42 pmRNSNet Asset Value(s)
28th Jun 201812:34 pmRNSNet Asset Value(s)
27th Jun 201812:39 pmRNSNet Asset Value(s)
26th Jun 201812:46 pmRNSNet Asset Value(s)
25th Jun 201812:47 pmRNSNet Asset Value(s)
25th Jun 20187:00 amRNSHalf-year Report
22nd Jun 201812:45 pmRNSNet Asset Value(s)
21st Jun 201812:08 pmRNSNet Asset Value(s)
21st Jun 20187:00 amRNSCorporate Action
20th Jun 201812:14 pmRNSNet Asset Value(s)
19th Jun 201812:39 pmRNSNet Asset Value(s)
18th Jun 201812:42 pmRNSNet Asset Value(s)
15th Jun 201812:51 pmRNSPortfolio Disclosures
15th Jun 201812:16 pmRNSNet Asset Value(s)
14th Jun 201811:59 amRNSNet Asset Value(s)
13th Jun 201811:53 amRNSNet Asset Value(s)
12th Jun 201811:50 amRNSNet Asset Value(s)
11th Jun 201811:27 amRNSNet Asset Value(s)
8th Jun 201812:55 pmRNSNet Asset Value(s)
7th Jun 20182:13 pmRNSMonth End Net Asset Value(s)
7th Jun 20181:01 pmRNSNet Asset Value(s)
6th Jun 201812:54 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.